InMed Pharmaceuticals Ownership & Insider Activity

InMed Pharmaceuticals (INM) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 7.5% of shares outstanding. Institutional investors hold 77.9%. Over the past 90 days, insiders made 3 purchases worth $151K.

Shares Outstanding

5.494M

Shares Float

5.472M

Insider Shares Owned

400.130K

Insider % Owned

7.5%

Institutional Shares Held

4.277M

Institutional % Held

77.9%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

$151K total

Sales (90d)

Net Activity

Net Buying

Net Value (90d)

$151K

InMed Pharmaceuticals Insider Transactions (Last 6 Months)

See all insider trades →

Date	Insider	Title	Type	Shares	Price	Value
Sep 14, 2026	ADAR Capital Management LLC, Daniel Schneeberger	10% OWNER	BUY	91.101K	$1.30	$118K
Jul 15, 2026	ADAR Capital Management LLC, Daniel Schneeberger	10% OWNER	BUY	1.000K	$1.55	$2K
Jul 14, 2026	Vivo Opportunity LLC, Vivo Opportunity Fund Holdings LP, Vivo Opportunity Cayman LLC, Vivo Opportunity Cayman Fund LP	10% OWNER	BUY	20.546K	$1.55	$32K
Jun 30, 2026	Vivo Opportunity LLC, Vivo Opportunity Fund Holdings LP, Vivo Opportunity Cayman LLC, Vivo Opportunity Cayman Fund LP	10% OWNER	BUY	6.551K	$1.55	$10K
May 20, 2026	Vivo Opportunity LLC, Vivo Opportunity Fund Holdings LP, Vivo Opportunity Cayman LLC, Vivo Opportunity Cayman Fund LP	10% OWNER	BUY	249.227K	$1.57	$392K
May 19, 2026	ADAR Capital Management LLC, Daniel Schneeberger	10% OWNER	BUY	468.551K	$1.54	$722K

More with Benzinga EdgeGet Access

InMed Pharmaceuticals Inc

InMed Pharmaceuticals Ownership & Insider Activity

InMed Pharmaceuticals Insider Transactions (Last 6 Months)

People Also Watch

People Also Watch